Pantoprazole 40 Mg Iv Austell 40 mg Powder for solution for injection.
PDF Leaflet Revision Date: 28 October 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Short-term treatment of duodenal ulcer, gastric ulcer, reflux oesophagitis, and Zollinger-Ellison syndrome.
Dosage (summary)
40 mg IV once daily; may use for up to 7 days.
Special Populations
- Elderly population
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established.
Key Drug Interactions
- Atazanavir
- Nelfinavir
- Clopidogrel
- Methotrexate
Contraindications
- Hypersensitivity to pantoprazole
- Severely impaired liver function
- Children under 18 years
Common side effects
- Injection site thrombophlebitis
- Clostridium difficile associated diarrhoea
- Headache
- Dizziness
Counselling Points
- Report any decrease in urine volume or blood in urine.
- Use the lowest effective dose for the shortest duration.
- Monitor for signs of renal function decline.
Serious warnings
- May mask gastric malignancy symptoms
- Risk of Clostridium difficile associated diarrhoea
- Acute interstitial nephritis
- Hypomagnesaemia
Important Disclaimer
The Pantoprazole 40 Mg Iv Austell 40 mg Powder for solution for injection. professional information leaflet below is the property of Austell Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
